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Background/Purpose: Although evidence suggests that gastroesophageal reflux disease (GERD) may 
interrupt sleep, the effects of symptomatic and endoscopically diagnosed GERD remain elusive because
the patient population is heterogeneous. Accordingly, we designed a cross-sectional study to assess their
association.
Methods: Consecutive participants in a routine health examination were enrolled. Definition and severity
of erosive esophagitis were assessed using the Los Angeles classification system. Demographic data, reflux
symptoms, sleep quality and duration, exercise amount, alcohol consumption, and smoking habits were
recorded. Factors affecting sleep quality and sleep duration were revealed by a polytomous logistic regression
analysis.
Results: A total of 3663 participants were recruited. Subjects with reflux symptoms, female gender, higher
body mass index, and regular use of hypnotics had poorer sleep quality. Exercise was associated with better
sleep quality. Either symptomatically or endoscopically, GERD did not disturb sleep duration. Among the
3158 asymptomatic patients, those with erosive esophagitis were more likely to have poor sleep quality.
The risk increased with the severity of erosive changes (p = 0.03).
Conclusion: The present study highlights the adverse effect of gastroesophageal reflux on sleep, even in
the absence of reflux symptoms. This finding has therapeutic implications in patients with silent erosive
disease, and future trials are warranted. [J Formos Med Assoc 2009;108(1):53–60]
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ORIGINAL ARTICLE
Sleep is essential for good health. Evidence has
shown that sleep disorders might contribute to
respiratory, hormonal, gastrointestinal, cardio-
vascular, and emotional impairment, while the
chronic dependence on hypnotics is a substantial
economic burden.1–4
Gastroesophageal reflux disease (GERD) may
play a pathogenic role in sleep disturbance.5–7
Nocturnal acid reflux can induce sensory stimuli
and esophageal clearance, and interrupt sleep-
stage progression, even in the absence of cognitive
awakening.8 In addition, reflux events during
sleep are characterized by longer acid-mucosal
contact that stems from lower saliva production,
lower frequency of swallowing, and slower gas-
tric emptying, all of which increase the risk of
mucosal damage, intensity of noxious stimuli, and
disruption of normal sleep.9,10
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Several trials have assessed the therapeutic 
effect of acid suppressants on sleep but the re-
sults were inconclusive. Johnson et al11 found that
proton-pump inhibitors (PPIs) can reduce night-
time heartburn, improve sleep quality, and thus
increase work efficacy. Dimarino et al12 found that
decreasing reflux-related arousal with acid sup-
pressant agents increases total sleep time and
rapid-eye movement sleep. However, using actig-
raphy to record sleep efficiency and percentage
immobility time, Chand et al13 found that PPIs
improve subjective but not objective measures 
of sleep quality. In addition, these studies were
mainly on patients with reflux symptoms and 
a favorable response could have been expected.
Reflux is a heterogeneous condition and can be
categorized as erosive and non-erosive reflux dis-
ease (NERD), as well as symptomatic and asymp-
tomatic. Among the general population, some
patients with erosive disease have no reflux symp-
toms, which may lower their awareness of the
disease and incentive for treatment.14–16 Therefore,
our aim was to assess the association between
GERD and sleep in subjects who were categorized
on the basis of their reflux symptoms and endo-
scopic findings.
Methods
Study design and population
This study was based on a voluntary, routine health
examination with a standard protocol conducted
at a single referral center. The protocol included
physical examination, blood chemical analysis,
plain radiography, abdominal ultrasonography,
and endoscopy. Our ethics committee approved
the study protocol before its implementation.
Most of the subjects received upper gastrointestinal
endoscopy since esophageal and stomach cancers
are prevalent in our country.17
Demographic data including age, gender, med-
ical history, exercise, smoking, alcohol consump-
tion, and body mass index (BMI) were recorded.
Symptoms suggestive of GERD (at least one epi-
sode of heartburn and acid regurgitation per week
in the past 3 months) were evaluated and vali-
dated during counseling with an internal medi-
cine specialist. These symptoms are considered to
be specific for GERD and are generally accepted
for use in population research.18 A Likert scale
embedded in the questionnaire assessed sleep
quality and sleep duration over the previous 
1-month period, including: (1) how do you rate
your sleep quality? (poor/acceptable/satisfactory);
and (2) how many hours on average do you
sleep at night? (< 5/5–6/6–7/7–8/ > 8).
Endoscopy
After an overnight fast, subjects were placed in
the left lateral decubitus position. Endoscopy
using Olympus GIF 240 or GIF 260 videoendo-
scopes (Tokyo, Japan) was performed by a single
group of endoscopists who had been trained at
the National Taiwan University Hospital. The
stomach and duodenum were inspected to ex-
clude possible lesions. The distal portion of the
esophagus was evaluated carefully to determine
the presence of mucosal injury. The esophagus was
carefully evaluated and all endoscopic findings
were meticulously recorded. Erosive esophagitis
was scored using the Los Angeles classification sys-
tem with standard comparator photographs.19 The
combining of four ordinal ratings into two cate-
gories (classes A/B and C/D) was intended to de-
crease variation in interpretation among observers
(change in overall κ from 0.45 to 0.65, which indi-
cated good consistency), and the procedure also
increased the statistical power for estimation.20
Statistical analysis
Continuous data were expressed as mean ±
standard deviation and categorical data as per-
centage. Logistic regression analysis was used to
estimate the effects of various risk factors associ-
ated with poor sleep quality and shorter sleep
duration. After the univariate models, we selected
the best subsets of risk factors by stepwise selec-
tion criteria, with entry and stay significance lev-
els of 0.2. We specified the categories of sleep
quality and sleep duration as outcome variables,
and a test for the trend was used to evaluate the
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possible dose-dependent relationship. The inter-
actions between predictive variables were also as-
sessed in each model. All statistical analyses were
performed using SAS version 9.1 (SAS Institute,
Cary, NC, USA) and p < 0.05 was considered statis-
tically significant.
Results
Demographic characteristics
After excluding subjects who refused endoscopy
and those who were not suitable for endoscopy
(n = 436), and those with missing sleep assess-
ment data (n = 1327), a total of 3663 participants
were enrolled between June 2003 and June 2004.
Their demographic data are shown in Table 1.
The mean age of those who were excluded from
analysis was 53.5 years, and 56.3% were male,
which was similar to the study group. Overall, en-
doscopic erosive esophagitis was detected in 653
of 3663 (17.8%) participants. Erosive esophagi-
tis with LA classification grades A/B and C/D was
diagnosed in 617 (16.8%) and 36 (1%) partici-
pants, respectively. Symptomatic reflux was re-
ported in 505 (13.8%) participants. Accordingly,
the population could be stratified into the fol-
lowing four categories: (1) no reflux symptom 
or erosive change (n = 2604, 71.1%); (2) NERD
(n = 406, 11.1%); (3) symptomatic erosive disease
(n = 99, 2.7%); and (4) asymptomatic erosive
disease (n = 554, 15.1%).
Regression analysis with poor sleep quality as
an outcome variable
In the logistic regression model using sleep quality
as an outcome variable (Table 2), reflux symp-
toms, female gender, higher BMI, endoscopic
erosive esophagitis, and use of hypnotics were
significant risk factors for poorer sleep quality.
After the multivariate adjustment and stepwise
model selection, reflux symptoms, female gen-
der, higher BMI, and use of hypnotics remained
significant. In contrast, more frequent or more
prolonged exercise was associated with better sleep
quality. For the aforementioned regression models,
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Table 1. Demographic characteristics of the study
population*
Characteristics Participants (n = 3663)
Mean age, yr 50.6 ± 11.83
Male gender 2128 (58)
Mean BMI (kg/m2)† 23.7 ± 3.4
< 18.5 110 (3)
18.5–24.9 2390 (65.2)
25.0–29.9 1018 (27.8)
≥ 30.0 145 (4)
Regular use of hypnotics 323 (8.8)
Reflux symptoms 505 (13.8)
Social habits
Smoking 601 (16.4)
Alcohol consumption 2508 (68.5)
Sleep parameters
Sleep duration (hr)
< 5 283 (7.7)
5–6 838 (22.9)
6–7 1610 (44)
7–8 771 (21)
> 8 161 (4.4)
Sleep quality
Poor 799 (21.8)
Acceptable 2098 (57.3)
Satisfactory 766 (20.9)
Exercise parameters
Exercise frequency
Rarely, < once per wk 1410 (38.5)
1–2 per wk 1073 (29.3)
3–4 per wk 582 (15.9)
5–6 per wk 407 (11.1)
≥ 7 per wk 191 (5.2)
Exercise duration 
per time (min)
< 10 1187 (32.4)
10–30 604 (16.5)
30–60 1044 (28.5)
> 60 828 (22.6)
Erosive esophagitis
Non-erosive 3010 (82.2)
LA A/B esophagitis 617 (16.8)
LA C/D esophagitis 36 (1)
*Quantitative data are expressed as mean ± standard deviation
and categorical data as n (%); †WHO classification (underweight
is < 18.5; normal is 18.5–24.9; overweight is 25.0–29.9; obese is
≥ 30.0 kg/m2). BMI = body mass index; LA = Los Angeles classifi-
cation of esophagitis.
the proportional odds assumption was justified.
It indicated that, for example, the presence of 
reflux symptoms was associated with 2.05-fold
(95% confidence interval, 1.65–2.54) increased
odds of reporting poorer sleep quality.
Regression analysis with shorter sleep
duration as an outcome variable
As a result of the small number of subjects with
sleep duration < 5 hours and > 8 hours, we com-
bined five ordinal ratings into three categories to
increase the statistical power for estimation: < 6
hours (n = 1121), 6–7 hours (n = 1612), and > 7
hours (n = 930). When examined as an outcome
variable (Table 3), shorter sleep duration was sig-
nificantly associated with female gender, older
age, higher BMI, and use of hypnotics. Smoking
and alcohol consumption, however, were associ-
ated with longer sleep duration. After the multi-
variate adjustment and stepwise model selection,
female gender, older age, higher BMI, and use of
hypnotics were independent factors for shorter
sleep duration. Proportional odds assumptions
were justified in all of these models.
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Table 2. Crude and adjusted OR of risk factors for poorer sleep quality
Crude OR Adjusted OR after model selection
OR 95% CI p Adjusted OR 95% CI p
Esophagitis
Erosive vs. non-erosive 1.25 1.06–1.47 0.008†
LA A/B vs. non-erosive 1.99 1.04–3.82 0.04†
LA C/D vs. non-erosive 1.54 0.81–2.9 0.19
Reflux symptoms 2.25 1.87–2.70 < 0.001† 2.05 1.65–2.54 < 0.001†
Female gender 1.65 1.45–1.87 < 0.001† 1.37 1.16–1.61 < 0.001†
Age (yr) 1.00 0.95–1.05 0.99
BMI (kg/m2)*
< 18.5 0.69 0.48–1 0.05
25.0–29.9 1.34 1.17–1.55 < 0.001†
≥ 30.0 1 0.72–1.38 0.98
p for linear trend 1.21 1.09–1.35 < 0.001† 1.03 1.01–1.05 0.007†
Smoking 1.00 0.84–1.20 1
Alcohol consumption 0.69 0.60–0.80 < 0.001†
Regular use of hypnotics 5.14 4.09–6.46 < 0.001† 4.70 3.55–6.24 < 0.001†
Exercise frequency*
≤ 1–2 per wk 0.56 0.49–0.64 < 0.001†
1–2 per wk 0.54 0.40–0.73 < 0.001†
3–4 per wk 0.47 0.38–0.59 < 0.001†
5–6 per wk 0.56 0.46–0.68 < 0.001†
≥ 7 per wk 0.59 0.50–0.69 < 0.001†
p for linear trend 0.81 0.77–0.86 < 0.001† 0.89 0.83–0.96 0.002†
Exercise duration*
10–30 min 0.63 0.51–0.78 < 0.001†
30–60 min 0.61 0.51–0.73 < 0.001†
> 60 min 0.55 0.45–0.67 < 0.001†
p for linear trend 0.82 0.77–0.87 < 0.001† 0.88 0.82–0.95 0.001†
*In the evaluations of BMI, exercise frequency and exercise duration, only linear trend models were evaluated by model selection: base-
line comparators of BMI were 18.5–24.9 kg/m2, rarely (i.e. < once per week) for exercise frequency, and < 10 minutes for exercise 
duration; †p < 0.05. OR = odds ratio; CI = confidence interval; LA = Los Angeles classification of esophagitis; BMI = body mass index.
Stratified analysis according to the form and
grade of reflux disease
Table 4 shows the stratification of the study pop-
ulation on the basis of form and grade of reflux
disease. In asymptomatic (n=3158) but not symp-
tomatic (n = 505) participants, erosive esophagi-
tis was significantly associated with poorer sleep
quality. In addition, the risk was increased with the
severity of erosive change (p=0.03 for linear trend).
No significant association was noted between
erosive changes and sleep duration.
Discussion
The present study analyzed the effects of GERD
on sleep in subjects with a spectrum of presenting
symptoms and endoscopic findings. We confirmed
that GERD itself was associated with poorer sleep
quality, regardless of the presence of erosive change.
Furthermore, this adverse effect was more perva-
sive than previously assumed, since it was exhib-
ited by a significant proportion of subjects with
silent erosive disease (554/653, 84.4%). In these
Gastroesophageal reflux disease and sleep
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Table 3. Crude and adjusted OR of risk factors for shorter sleep duration
Crude OR Adjusted OR after model selection
OR 95% CI p Adjusted OR 95% CI p
Esophagitis
Erosive vs. non-erosive 0.99 0.85–1.14 0.86
LA A/B vs. non-erosive 0.84 0.47–1.51 0.57
LA C/D vs. non-erosive 1.02 0.88–1.19 0.52
Reflux symptoms 1.10 0.95–1.29 0.22
Female gender 1.26 1.14–1.40 < 0.001‡ 1.34 1.15–1.56 < 0.001‡
Age (yr) 1.26 1.20–1.31 < 0.001‡ 1.16 1.09–1.24 < 0.001‡
BMI (kg/m2)*
< 18.5 0.70 0.52–0.94 0.02‡
25.0–29.9 0.94 0.83–1.07 0.36
≥ 30.0 1.47 1.06–2.04 0.02‡
p for linear trend 1.15 1.04–1.26 0.005‡ 1.04 1.02–1.06 0.001‡
Smoking 0.74 0.63–0.87 < 0.002‡
Alcohol consumption 0.81 0.72–0.92 < 0.001‡
Regular use of hypnotics 1.75 1.44–2.12 < 0.001‡ 1.45 1.12–1.91 0.007‡
Exercise frequency†
≤ 1–2 per wk 0.99 0.88–1.11 0.89
1–2 per wk 0.88 0.68–1.15 0.35
3–4 per wk 0.79 0.42–1.16 0.56
5–6 per wk 0.96 0.81–1.14 0.66
≥ 7 per wk 1.11 0.96–1.27 0.16
p for linear trend 1.06 0.89–1.26 0.23
Exercise duration†
10–30 min 0.98 0.81–1.18 0.87
30–60 min 0.92 0.78–1.08 0.18
> 60 min 1.06 0.89–1.26 0.23
p for linear trend 0.99 0.94–1.05 0.83
*Only linear trend items were inputted into the model selection process in the evaluation of BMI (baseline comparator of BMI was
18.5–24.9 kg/m2); †baseline comparators were < once per week for exercise frequency and < 10 minutes for exercise duration;
‡p < 0.05. OR = odds ratio; CI = confidence interval; LA = Los Angeles classification of esophagitis; BMI = body mass index.
subjects, we observed a parallel increase in severity
of erosive change with reduced sleep quality, which
might strengthen the linkage between GERD and
sleep disorders.
Our results suggest that the presence of reflux
symptom is an independent risk factor for poorer
sleep quality. GERD symptoms are mediated
through afferent stimuli from the lower esophagus
and gastric fundus to the sensory nucleus in the
medulla, and then through efferent signals that
mediate transient lower esophageal sphincter re-
laxation.21 We assume that subjects with erosive
esophagitis or visceral hypersensitivity have more
frequent sensory input from the esophagus, and
that this input interrupts sleep progression by 
activating the wake-promoting neurons (located
in the posterior hypothalamus, basal forebrain,
and mesopontine tegmentum) and inhibits the
sleep-promoting neurons (located in the preoptic
area of the anterior hypothalamus).22
By monitoring cardiac autonomic activity and
ambulatory pH measurement, our previous study
has shown a generalized decrease in cardiac au-
tonomic function in response to intraesophageal
pH during waking or sleeping hours.23 Bajaj et al
have shown that only a minute amount of fluid
in the proximal esophagus can induce arousal
during stage III/IV non-rapid eye movement sleep,
before esophageal sphincter contractile reflux
and secondary peristalsis are activated.24 Using
functional magnetic resonance imaging, Kern 
et al found that esophageal mucosal contact with
acid, at a level below that needed to stimulate
heartburn, can induce neuronal activity to evoke
a cerebral cortical response.25 These findings
support the hypothesis that the central nervous
system receives sensory stimuli from the intraeso-
phageal lumen that may subconsciously interrupt
sleep.
As poorer sleep quality is associated with in-
creased sympathetic activity and blood pressure,
decreased glucose tolerance, and thus a higher
risk of cardiovascular events,26 several therapeutic
trials have evaluated the beneficial effect of acid
suppressants on sleep in patients with sympto-
matic GERD. Johnson et al confirmed that PPI
therapy might improve sleep quality and work
productivity.11 Dimarino et al found that arousal
from sleep is related closely to acid reflux, and
acid suppression may reduce the frequency of
arousal.12 Orr et al have shown that acid suppres-
sion can improve sleep quality in symptomatic
GERD patients.27–29 Shaheen et al found that a
significant minority of subjects with insomnia
(4/16, 25%) had abnormal acid exposure and
PPI treatment might be of benefit.30
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Table 4. Influence of endoscopic esophagitis on poorer sleep quality and shorter sleep duration, stratified by
form and grade of reflux disease
Reflux − (n = 3158) Reflux + (n = 505)
OR 95% CI p OR 95% CI p
Sleep quality
Esophagitis vs. non-erosive 1.27 1.06–1.52 0.01* 1.31 0.86–2.00 0.21
LA A/B vs. non-erosive 1.31 1.09–1.57 0.03* 0.72 0.47–1.12 0.20
LA C/D vs. non-erosive 1.43 0.70–2.94 0.18 1.52 0.36–6.46 0.43
LA C/D vs. LA A/B 1.89 0.91–3.85 0.09 2.13 0.48–9.09 0.33
p for linear trend 1.20 1.02–1.42 0.03* 1.20 0.82–1.76 0.35
Sleep duration
Esophagitis vs. non-erosive 1.02 0.87–1.19 0.80 0.98 0.67–1.45 0.92
LA A/B vs. non-erosive 0.98 0.83–1.15 0.84 0.97 0.65–1.45 0.42
LA C/D vs. non-erosive 1.03 0.53–1.99 0.90 1.71 0.49–5.95 0.39
LA C/D vs. LA A/B 1.05 0.54–2.04 0.84 1.75 0.49–6.25 0.42
p for linear trend 1.02 0.88–1.18 0.83 0.94 0.67–1.33 0.73
*p < 0.05. OR = odds ratio; CI = confidence interval; LA = Los Angeles classification of esophagitis.
It has been recognized that sleep duration can
have important effects on health with a U-shaped
association between sleep duration and mortal-
ity rate.31 Prolonged sleep is associated with an
increased risk of morbidity and mortality, and
sleep deprivation may alter neurohormonal reg-
ulation, which predisposes to disease. In sympto-
matic GERD patients, one clinical trial has found
that acid suppression therapy might increase the
total sleep time.12 In our study with an epidemi-
ologic design, however, we did not identify any
significant association between GERD and sleep
duration. This discrepancy might be related to the
differences in study design and the use of acid
suppressants.32
Our results are credible for several reasons.
First, this study included a large number of pa-
tients with complete clinical data. Asymptomatic
subjects were evaluated to elucidate the relation-
ship between intraesophageal damage and sleep.
Also, the simultaneous evaluation of symptomatic
and asymptomatic subjects enabled us to assess
the effect of GERD alone on sleep, and high-
lighted the need for further clinical trials. Second,
our endoscopists completed the same training
program and used a standardized rating proto-
col. This procedure substantially decreased inter-
observer variability in endoscopic grading and
enhanced our ability to identify the association.
However, our study had limitations. The first
limitation involved the study sample. Subjects were
obtained via advertisement at a routine health
examination and therefore probably represent a
population with intermediate GERD severity be-
tween that of subjects recruited from GI clinics
and those randomly selected from the general
population. A small number of patients with class
C/D esophagitis might have produced insufficient
statistical power in this category. Second, the in-
formation about sleep quality and duration was
self-reported and was not based on objective mea-
surement, although Lockley et al have suggested
that self-reported assessment is as valid as actig-
raphy.33 In addition, we used a simplified rating
scale to assess sleep parameters, but sleep quality
is complicated, and may be affected by multiple
factors including sleep initiation and maintenance,
early awakening, and sleep duration. Several bio-
logical and psychosocial factors (e.g. menopause
in women, anxiety and depression) were involved
but not evaluated in our study. Further studies
using an extensive and well-validated question-
naire, including the Pittsburgh Sleep Quality Index
and a diary to record sleep duration might better
reflect the overall sleep-related symptoms.34 Third,
although endoscopy is the most accurate method
for diagnosis of GERD, misclassification of ero-
sive disease as NERD, or vice versa, is still possi-
ble.19 Therefore, we may have underestimated the
impact of morphologic changes on sleep because
detection of subtle erosive changes, especially in
NERD subjects, was limited. Finally, sleep disor-
der is a heterogeneous disease entity that includes
insomnia, sleep apnea and narcolepsy.35 The inter-
pretation of our results may not apply to patients
with severe sleeping disorders.
In conclusion, our study clarified the relation-
ship between GERD (as defined endoscopically
and symptomatically) and sleep in a Chinese pop-
ulation. The results may underscore the adverse
effect of acid reflux on sleep quality, which may
have therapeutic implications in patients with
silent erosive disease. Future trials are therefore
warranted.
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